Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)
Clinical trial NCT05689047 · COMPLETED
Trial details
- NCT number
- NCT05689047
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2024-05-28
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.